sFlt-1/ANG-II ratio is a promising predictor for adverse outcomes such as pneumonia, ICU admission, intubation, viral sepsis, and death in pregnant women with COVID-19. The gene discussed is AGT; the disease is susceptibility to pneumonia measurement.